(Q71977305)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642566%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Insulin-like growth factor I receptor activated by a transmembrane mutation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642566%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

Insulin-like Growth Factor I Receptor Activated by a Transmembrane Mutation (English)

1 reference

https://api.crossref.org/works/10.1074/JBC.270.32.19041

8 July 2024

author name string

K. Takahashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642566

8 July 2024

K. Yonezawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642566

8 July 2024

I. Nishimoto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642566

8 July 2024

language of work or name

English

0 references

publication date

1 August 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642566%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

11 August 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7642566

full work available at URL

8 July 2024

http://www.jbc.org/article/S0021925818519438/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7642566

https://api.elsevier.com/content/article/PII:S0021925818519438?httpAccept=text/xml

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.32.19041

https://api.elsevier.com/content/article/PII:S0021925818519438?httpAccept=text/plain

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.32.19041

https://syndication.highwire.org/content/doi/10.1074/jbc.270.32.19041

8 July 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.32.19041

Journal of Biological Chemistry

8 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642566%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642566%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642566%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

19041-19045

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642566%20AND%20SRC:MED&resulttype=core&format=json

Insulin-like growth factors I and II.

22 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Monoclonal antibody alpha IR-3 inhibits the ability of insulin-like growth factor II to stimulate a signal from the type I receptor without inhibiting its binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Involvement of p21ras in activation of extracellular signal-regulated kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin and insulin-receptor substrate 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

The src oncogene can regulate a human glucose transporter expressed in chicken embryo fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like-growth-factor-I-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

A dominant-negative mutant of mSOS1 inhibits insulin-induced Ras activation and reveals Ras-dependent and -independent insulin signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.32.19041

Activation of extracellular signal-regulated kinase, ERK2, by p21ras oncoprotein

21 January 2018

23

1 reference

https://api.crossref.org/works/10.1074/JBC.270.32.19041

Requirement of MAP kinase for differentiation of fibroblasts to adipocytes, for insulin activation of p90 S6 kinase and for insulin or serum stimulation of DNA synthesis.

8 July 2024

28

1 reference

https://api.crossref.org/works/10.1074/JBC.270.32.19041

8 July 2024

32

54

2472

Miura

1994

1 reference

https://api.crossref.org/works/10.1074/JBC.270.32.19041

8 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7642566%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference